VGICX | VIVAX | VGICX / VIVAX | |
Total Expense Ratio | 1.44 | 0.17 | 847% |
Annual Report Gross Expense Ratio | 1.50 | 0.17 | 882% |
Fund Existence | 28 years | 33 years | - |
Gain YTD | 6.815 | 6.724 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.51B | 195B | 3% |
Annual Yield % from dividends | 0.90 | 2.06 | 43% |
Returns for 1 year | 9.06 | 9.76 | 93% |
Returns for 3 years | 36.11 | 34.31 | 105% |
Returns for 5 years | 78.01 | 74.87 | 104% |
Returns for 10 years | 86.28 | 116.32 | 74% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RMDAX | 5.41 | 0.06 | +1.12% |
Virtus Silvant Mid-Cap Growth A | |||
TSCPX | 12.35 | 0.09 | +0.73% |
AMG TimesSquare Small Cap Growth N | |||
WTRCX | 12.82 | 0.05 | +0.39% |
Macquarie Core Equity Fund Class C | |||
CWIEX | 72.06 | 0.04 | +0.06% |
American Funds Capital World Gr&Inc 529E | |||
ETAHX | 33.72 | -0.01 | -0.03% |
Eventide Healthcare & Life Sciences A |